NLC are the new generation of nanoparticulate active substance vehicles and are attracting major attention as novel colloidal drug carriers for topical use.
NLC systems with good perspectives to be marketed very successfully, reason for this is they were developed considering industrial needs, e.g. scale up, qualification and validation, simple technology, low cost, regulatory excipient status (e.g. GRAS), tolerability etc.
Today HPH represents an efficient pathway for production of NLC as novel systems composed of physiological lipid materials suitable for topical, dermal administration novel drug delivery system.
Nanostructured lipid carriers hold great promise for reaching the goal of controlled and site specific drug delivery and hence attracted wide attention of researchers.
